Join to View Full Profile
1500 Owens StSan Francisco, CA 94158
Dr. Vandevrede is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2015 - 2018
University of Illinois College of Medicine
Certifications & Licensure
CA State Medical License 2018 - 2025
MA State Medical License 2014 - 2018
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Correction to: Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.Lawren VandeVrede, Renaud La Joie, Sheena Horiki, Nidhi S Mundada, Mary Koestler
Acta Neuropathologica. 2025-02-13 - 1 citationsDetection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.Lawren VandeVrede, Hanna Cho, Mark Sanderson-Cimino, Fattin Wekselman, Yann Cobigo
JAMA Neurology. 2025-02-10 - Clinical and neuropathological associations of plasma Aβ/Aβ, p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders.Binita Rajbanshi, Igor Prufer Q C Araujo, Lawren VandeVrede, Peter A Ljubenkov, Adam M Staffaroni
Alzheimer's & Dementia. 2025-01-29
Press Mentions
P-tau 217 Detects Alzheimer’s Pathology in Neurodegenerative SyndromesFebruary 24th, 2025- Blood Test Detects Alzheimer's Pathology in Other Clinical SyndromesFebruary 10th, 2025
- Coroner Confirms Death in Two-Vehicle Crash on First Street in CanonsburgJuly 28th, 2024
- Join now to see all
Grant Support
- Validation of Novel Plasma Biomarkers for Mixed Etiology DementiaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
